David Montecalvo is Senior Vice President & Chief Global Operations and Supply Chain Officer of West Pharmaceutical Services Inc. On 28 July 2020 he exercised 19,150 units of WST stock for $1,472,444.
Montecalvo joined West in September 2016, bringing with him 30 years of experience in the medical device industry. Prior to joining, he held various senior leadership roles at Medtronic plc including Vice President, Contract Manufacturing Operations of its Restorative Therapies Group and Vice President, Business Operations Integration.
Early Life and Education
Experiences early in a child’s life have an enormous influence on his or her future learning capacity, behaviors, physical health and mental wellbeing. At this stage of development, the brain grows at an unprecedented rate.
Children begin learning about themselves and their world in various ways, including from parental instruction. But for healthy development, children require active stimulation from others as well.
Early Childhood Education (ECE) refers to the practice of providing essential development milestones and skills through formalized settings from birth through eight years old. Early Childhood Education is recognized by UNESCO as a core aspect of education that facilitates national improvements in prosperity, social inclusion and economic development.
David Montecalvo has built an outstanding career over 35 years in the pharmaceutical industry. He has held various leadership roles at Urologix and Medtronic – such as being Chief Operating Officer and Senior Vice President respectively.
At West Pharmaceutical Services, he currently holds the role of Senior Vice President and Chief Operating and Supply Chain Officer. His expertise has enabled them to realize significant accomplishments in terms of increasing efficiency while decreasing costs.
As of 28 July 2020, this individual owned 19150 shares of WST stock valued at over $3,515,348. He had made several trades since 2020; one worth over $1,472,444 was exercised on 28 July 2020 alone. Most likely a longtime stockholder, conducting financial analyses can help assess their worth accurately.
Achievement and Honors
David Montecalvo brings over 35 years of experience to West Pharmaceutical Services as Senior Vice President, Global Operations and Supply Chain in September 2016.
He was responsible for launching a new product line and spearheading company-wide restructuring efforts, while also playing a pivotal role in integrating a new supply chain function into the organization.
An expert in his field, Mr. Lee holds numerous accolades. These include being certified Lean Black Belt, an Advisory Board member to Boeing Center for Supply Chain Innovation and holding seven patents. As former executives with Medtronic and Urologix as well as 30 years experience working within medical device industries he boasts both degrees from Case Western Reserve University as well as experience.
David Montecalvo serves as Senior Vice President, Global Operations and Supply Chain Officer for West Pharmaceutical Services Inc. since September 2016.
Prior to joining West, he held various leadership positions with Medtronic plc including Vice President for Contract Manufacturing Operations of Restorative Therapies Group and Vice President Business Operations Integration.
Robert has over three decades of experience in the medical device and life science industries, holding senior operations and product development roles at Urologix Inc. and LecTec Corporation.
He was the son of Saverio and Grace (Parrillo) Montecalvo and survived by his devoted wife Angeline as well as four of their five children: Pamela Montecalvo (Rick), Judith Olano (John), David Wasgatt III (Cynthia), and Douglas Wasgatt IV (Blaky). Furthermore, 16 grandchildren and 28 great-grandchildren also adore him!
David Montecalvo is Senior Vice President and Chief Operating and Supply Chain Officer for West Pharmaceutical Services Inc, boasting a net worth of $2 Million as of April 15, 2023-04-15. He owns 6,309 shares of West Pharmaceutical Services stock; has made one insider trade since 2020; exercised 19,150 units for $1.472,444 on 28 July 2020
He currently serves as Chairman of Urologix, Inc. and LecTec Corporation’s boards. With 30 years of experience in medical device and life science industries, he holds an MBA from University of St Thomas as well as a bachelor’s degree in biomedical engineering from Case Western Reserve University – in addition to belonging to American Institute of Biomedical Engineers (AIBE).